文献速递甲状腺疾病

血浆代谢组学揭示亚临床和临床甲状腺功能减退症的全身代谢改变

Plasma Metabolomics Reveals Systemic Metabolic Alterations of Subclinical and Clinical Hypothyroidism.
PubMed 文献 · J Clin Endocrinol Metab · 2022-01-01

该研究纳入126名受试者(45例临床甲减、41例亚临床甲减、40例甲状腺功能正常对照),采用高分辨率质谱代谢组学分析血浆样本。结果显示亚临床甲减和临床甲减组代谢模式显著不同于对照组,但两组间代谢改变高度相似;通路富集分析涉及初级胆汁酸生物合成、类固醇激素生物合成、赖氨酸降解、色氨酸代谢和嘌呤代谢;筛选并验证17种代谢标志物可区分三组。

要点

  • 亚临床甲减和临床甲减患者血浆代谢模式显著不同于甲状腺功能正常者。
  • 亚临床甲减与临床甲减之间的代谢改变高度相似。
  • 17种代谢标志物结合机器学习模型可区分临床甲减、亚临床甲减和对照三组。

核心结论

  • 亚临床甲减和临床甲减存在与甲状腺功能减退相关的显著代谢模式改变。
  • 代谢组学结合机器学习算法可基于所选代谢物开发诊断模型。

研究设计与样本

  • 研究纳入126名人类受试者,包括45例临床甲减患者、41例亚临床甲减患者和40例甲状腺功能正常对照。
  • 采用基于高分辨率质谱的代谢组学分析血浆样本。
  • 数据通过多变量主成分分析和正交偏最小二乘判别分析处理,相关性分析采用多变量线性回归分析。
  • 使用R算法中的无偏变量选择和3种机器学习模型开发基于潜在代谢生物标志物的预测模型。

主要发现

  • 亚临床甲减组和临床甲减组的血浆代谢组模式与对照组显著不同,而亚临床甲减组与临床甲减组之间的代谢物改变高度相似。
  • 通路富集分析发现亚临床甲减和临床甲减对初级胆汁酸生物合成、类固醇激素生物合成、赖氨酸降解、色氨酸代谢和嘌呤代谢有显著影响。
  • 发现65种代谢物与促甲状腺激素、游离甲状腺素、甲状腺过氧化物酶抗体或甲状腺球蛋白抗体水平存在显著关联。
  • 成功选择并验证了17种代谢生物标志物以区分3组。

关键数值与推荐

  • 共纳入126名受试者:临床甲减45例、亚临床甲减41例、甲状腺功能正常对照40例。
  • 65种代谢物与促甲状腺激素、游离甲状腺素、甲状腺过氧化物酶抗体或甲状腺球蛋白抗体水平显著相关。
  • 17种代谢生物标志物被选择并验证用于区分临床甲减、亚临床甲减和对照三组。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Clinical hypothyroidism (CH) and subclinical hypothyroidism (SCH) have been linked to various metabolic comorbidities but the underlying metabolic alterations remain unclear. Metabolomics may provide metabolic insights into the pathophysiology of hypothyroidism. OBJECTIVE: We explored metabolic alterations in SCH and CH and identify potential metabolite biomarkers for the discrimination of SCH and CH from euthyroid individuals. METHODS: Plasma samples from a cohort of 126 human subjects, including 45 patients with CH, 41 patients with SCH, and 40 euthyroid controls, were analyzed by high-resolution mass spectrometry-based metabolomics. Data were processed by multivariate principal components analysis and orthogonal partial least squares discriminant analysis. Correlation analysis was performed by a Multivariate Linear Regression analysis. Unbiased Variable selection in R algorithm and 3 machine learning models were utilized to develop prediction models based on potential metabolite biomarkers. RESULTS: The plasma metabolomic patterns in SCH and CH groups were significantly different from those of control groups, while metabolite alterations between SCH and CH groups were dramatically similar. Pathway enrichment analysis found that SCH and CH had a significant impact on primary bile acid biosynthesis, steroid hormone biosynthesis, lysine degradation, tryptophan metabolism, and purine metabolism. Significant associations for 65 metabolites were found with levels of thyrotropin, free thyroxine, thyroid peroxidase antibody, or thyroglobulin antibody. We successfully selected and validated 17 metabolic biomarkers to differentiate 3 groups. CONCLUSION: SCH and CH have significantly altered metabolic patterns associated with hypothyroidism, and metabolomics coupled with machine learning algorithms can be used to develop diagnostic models based on selected metabolites.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Shao F, Li R, Guo Q, et al. Plasma Metabolomics Reveals Systemic Metabolic Alterations of Subclinical and Clinical Hypothyroidism. J Clin Endocrinol Metab. 2022. PMID: 36181451. doi:10.1210/clinem/dgac555

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。